EXOZ
eXoZymes, Inc.
NASDAQ: EXOZ · HEALTHCARE · BIOTECHNOLOGY
$9.98
-3.57% today
Updated 2026-04-30
Market cap
$87.31M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$7 – $18
Volume
0.0M
eXoZymes, Inc. (EXOZ) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-1.59M | $-1.26M | $-1.18M | $-8.51M | $-6.50M |
| Capital expenditures | $422586.00 | $185983.00 | $288712.00 | $396451.00 | $169917.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | $198461.00 | $216503.00 | $281538.00 | $1.13M | $1.99M |
| Free cash flow | $-2.01M | $-1.44M | $-1.47M | $-8.90M | $-6.67M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |